Despite anti-CD44 treatment being the most effective at preventing AML adhesion, some AML cells (using both cell lines and primary AML cells) remained persistently adhered and viable, even in the presence of the highest dose of anti-CD44 and high (micromolar) concentrations of cytarabine. This evidence concerns the gene CD44 and acute myeloid leukemia.